Contact Form

Name

Email *

Message *

Showing posts with label diabetes. Show all posts
Showing posts with label diabetes. Show all posts

Wednesday, March 14, 2018

Cancer, Cars, Diabetes And Heart Attacks More Deadly Than Guns. Why No School Assemblies About These Killers?

The 4 Things Deadlier Than Guns

  • 03/14/2018 
  • Source: TTN
  •  
  • by: TTN Staff
28 21 3  80
image: https://structurecms-staging-psyclone.netdna-ssl.com/client_assets/trumptrain/media/picture/5aa9/5eec/6970/2d4a/da7e/6100/content_Declaration_of_Independence__with_Firearm.jpg?1521049324
The 4 Things Deadlier Than Guns
By KAZ Vorpal (Flickr: Declaration of Independence, with Firearm) [CC BY-SA 2.0 (https://creativecommons.org/licenses/by-sa/2.0)], via Wikimedia Commons

Liberal teachers are indoctrinating gullible young students against guns.
 Suddenly, kids from a country that, according to Pew, ranks 38th out of 71 
countries in the world on math are lecturing us with gun violence statistics.
Ironically, kids that have been failed in their math classes by hack teachers
are lecturing us with an invalid interpretation of evidence. Will they protest
their teachers? They should. They were taught how to test, not how to think.

Rather than holding out hope that anti-gun students will see the light, we're
going to show you a few things that are obviously more lethal than gun
ownership. Feel free to use this page to slap down bad arguments about guns.


Read more at http://trumptrainnews.com/articles/the-4-things-deadlier-than-guns#1sRcmVruEzM1Wf6C.99

Tuesday, January 2, 2018

Usually Cures Are Found By Accident

(CBS Local) — Although their goal was to cure diabetes, scientists may have stumbled onto a new medication to help treat the devastating effects of Alzheimer’s disease.
According to a press release from researchers at Lancaster University, a new drug being tested for diabetes patients was found to have “significantly reversed memory loss” in test subjects and is now being examined as possible treatment for neurodegenerative disorders.
The medication, known as a triple receptor drug — or “triple agonist” — reportedly works in multiple ways to protect the brain against degeneration and promote growth. Researchers say that a study of mice being given the drug found that the animals had an increased ability to learn and retain memories.
“These very promising outcomes demonstrate the efficacy of these novel multiple receptor drugs that originally were developed to treat type 2 diabetes,” Professor Christian Holscher said in the release.
The scientists added that the mice showed a decrease in chronic inflammation and amyloid plaques in the brain, which have been linked to the development of Alzheimer’s in people.
“With no new treatments in nearly 15 years, we need to find new ways of tackling Alzheimer’s,” Dr. Doug Brown of the Alzheimer’s Society said. “It’s imperative that we explore whether drugs developed to treat other conditions can benefit people with Alzheimer’s.”
The discovery of the diabetes drug’s side-effect is not a complete coincidence to the researchers. The findings, published in the journal Brain Research, point to the link between some of the symptoms of diabetes and their link to Alzheimer’s. Insulin desensitisation is not only one of the key effects suffered by diabetes patients, the hormone’s lack of production has also reportedly been observed in the brains of people affected by the memory-stealing disorder.

Friday, September 26, 2014

We Have Not Had Artificial Sweeteners For Years. We Knew They Were Bad For You.

Israeli Study Shows Artificial Sweeteners Not So Good for You After All

“It is not good to eat much honey; so for men to search out their own glory is not glory.” (Proverbs 25:27)
A new study by the Weizmann Institute of Science in Israel calls into question the alleged safety of artificial sweeteners.  In fact, says one researcher, they may even do the very thing users are trying to prevent.
“In our studies we found that artificial sweeteners may drive, or contribute to…an exaggerated elevation in blood glucose levels – the very same condition that we often aim to prevent by consuming them,” said Dr. Eran Elinav of the Immunology Department.  He led the study, along with Prof. Eran Segal from the Computer Science and Applied Mathematics Department.
The results of the experiments conducted were published in the journal Nature on Wednesday.  Although the extent of the research was not enough for the scientists to make recommendations, they are suggesting further investigation is warranted.
The research team conducted a variety of experiments to test their theory that artificial sweeteners alter the body’s microbiome, or collection of bacteria present in the digestive system.  Altering the microbiome can lead to elevated glucose levels which remain high for longer periods after eating. This glucose intolerance is a precursor to diabetes.
In the first experiment, the scientists fed groups of mice different compounds – plain water, sugar water, or artificially sweetened water.  After one week, all three groups were given a dose of sugar, and the effects were monitored.  The first two groups showed no difference in blood sugar levels, but the mice fed the artificially sweetened water showed a marked glucose intolerance. The same was true whether the artificial sweetener used was saccharin (used in Sweet ‘N Low); sucralose (Splenda), or aspartame (Equal).
Another experiment, involving injecting intestinal bacteria from saccharin-fed mice into healthy mice, demonstrated that the recipient mice developed the same glucose intolerance, and the that the microbiomes of the mice who had consumed the saccharin were indeed different.
To test the effect on humans, the researchers surveyed 381 non-diabetic participants and discovered a correlation between reported sweetener use and glucose intolerance.  The sweetener users also had altered intestinal bacteria.
A final experiment saw seven healthy adults who do not normally use artificial sweeteners consume the FDA maximum recommended daily intake for six days.  Four of the seven showed signs of glucose intolerance following the experiment.  Additionally, the three participants who did not show a change in blood-glucose levels also had different intestinal bacteria than those who did.  This seems to suggest probiotics may be useful in treating glucose intolerance.
The results of Elinav and Segal’s research are compelling, but not conclusive.  “This research raises caution that artificial sweeteners may not represent the ‘innocent magic bullet’ they were intended to be to help with the obesity and diabetes epidemics, but it does not yet provide sufficient evidence to alter public health and clinical practice,” said Nita Forouhi, program leader at the Medical Research Council’s epidemiology unit at Cambridge University.
Meanwhile, the FDA issued a statement reminding the public that artificial sweeteners “have been thoroughly studied and have a reasonable certainty of no harm to consumers.”
Still, the study provides some ‘food for thought’, so to speak.  Even its author has been moved by what he has seen.
“I’ve consumed very large amounts of coffee, and extensively used sweeteners, thinking like many other people that they are at least not harmful to me and perhaps even beneficial,” Elinav said. “Given the surprising results that we got in our study, I made a personal preference to stop using them.
“We don’t think the body of evidence that we present in humans is sufficient to change the current recommendations,” he continued. “But I would hope it would provoke a healthy discussion.”

Read more at http://www.breakingisraelnews.com/21908/israeli-study-shows-artificial-sweeteners-good/#dWwvJb0yCphxJmtO.99

Monday, November 18, 2013

New Statin Regime: Does It Mean Eternal Life Or Will Side Effects Be Worse Than The Medicine?

Don't Rush to Get a Statin: Top Heart Doctor

Wednesday, 13 Nov 2013 12:11 PM
By Charlotte Libov
Share:
More . . .
A    A   |
   Email Us   |
   Print   |
Will there be a statin stampede?
 
That’s what health authorities are asking in the wake of groundbreaking new cholesterol guidelines that some predict will result in twice as many Americans taking the already-popular statin medications.
 
However, one of the nation’s top cardiologists says that those worried about heart health should be cautious before jumping on the statin bandwagon. “I’m not against statins.They are lifesavers for many of my patients. But these broad guidelines play into the myth that Americans can solve their health problems by popping a pill,” says Chauncey Crandall, M.D., director of preventative medicine and clinical cardiology at the Palm Beach Cardiovascular Clinic.



“These drugs don't remedy the health problems that our lifestyle has brought us.”
 
Dr. Crandall recommends a wait-and-see approach to the new guidelines. “We’ve made great progress over the past 25 years,” he said. “I don’t think we should abandon a successful strategy until we have time to evaluate how the new one is working.”
 
The American Heart Association and the American College of Cardiology announced the new joint guidelines on Tuesday. They are the first major change in a decade, and they mark a dramatic shift in the way statin drugs are prescribed. Key changes include the jettisoning of familiar cholesterol number goals and a broadening of the definition of who should take statins.
 
Under the old guidelines, doctors were urged to bring patients down to cholesterol target numbers, including a total cholesterol count of less than 200, with low-density LDL cholesterol (the so-called “bad” cholesterol) under 100. People with heart disease, were advised to keep their total cholesterol level under 150 and their LDL cholesterol below 70.
 
Dr. Crandall, author of the number one Amazon best-seller The Simple Heart Cure: The 90-day Program to Stop and Reverse Heart Disease, is skeptical of reducing the importance of hitting cholesterol targets. “We shouldn’t be backing off treating these individuals to goal,” he said. “These targets work well, people are accustomed to them, and changing them now will cause confusion.”



>>>>>>>>Under the new guidelines, cholesterol numbers are just part of a larger set of factors that doctors will use to determine whether a person should take a statin. The new risk calculator also considers blood pressure, age, risk for diabetes, stroke, and other factors. Most experts agree that they set a lower threshold for taking statins, which include Lipitor, Zocor, and Crestor. As a result, some 70 million Americans could end up on the medications. About 32 million take statins now.
 
Dr. Crandall, author of the Heart Health Report newsletter, says he doesn’t plan to change the way he prescribes statins, at least in the near future.

“We are going the same way we have been for a year or two until the dust settles over the new guidelines,” he told Newsmax Health. “We’re staying true to what we’ve been doing because we have a system that we know works.”
 
The new guidelines downplay the importance of lifestyle changes, which for many people can accomplish the same goals as the powerful statin drugs without potential side effects that include increased diabetes risk, muscle disorders, and mental confusion, he said.
 
 

“Doctors tend to put the emphasis on statins, but we also know that a plant-based diet also has a tremendous impact on preventing and reversing heart disease,” said Dr. Crandall.
 
© 2013 NewsmaxHealth. All rights reserved.